BIOSYNTH AS

4327 SANDNES

Finances

Share Ownership

Return on Equity

−344,47 %

Current Ratio

1,11

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	421 000	631 000	1 524 000	620 000
Net Income	−11 898 000	−11 228 000	−7 601 000	−6 062 000
Total Assets	17 095 000	16 402 000	6 582 000	5 677 000
Total Equity	3 454 000	3 352 000	4 580 000	4 681 000

Income (NOK)	2022	2021	2020	2019
Revenue	421 000	631 000	1 524 000	620 000
Expenditure	12 199 000	11 764 000	9 081 000	6 759 000
Operating Profit	−11 785 000	−11 133 000	−7 583 000	−6 151 000
Financial Income	11 000	2 000	18 000	90 000
Financial Costs	123 000	98 000	35 000	0
Financial Balance	−112 000	−96 000	−17 000	90 000
Earnings Before Tax	−11 898 000	−11 228 000	−7 601 000	−6 062 000
Tax	0	0	0	0
Net Income	−11 898 000	−11 228 000	−7 601 000	−6 062 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 982 000	2 123 000	2 112 000	843 000
Total Current Assets	15 113 000	14 280 000	4 470 000	4 834 000
Total Assets	17 095 000	16 402 000	6 582 000	5 677 000
Total Retained Equity	−1 126 000	−1 228 000	0	−3 649 000
Total Equity	3 454 000	3 352 000	4 580 000	4 681 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	13 640 000	13 050 000	2 002 000	996 000
Total Equity and Debt	17 095 000	16 402 000	6 582 000	5 677 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	421 000	631 000	1 524 000	620 000
Other Income	0	0	0	0
Revenue	421 000	631 000	1 524 000	620 000
Cost of Goods Sold	271 000	302 000	157 000	55 000
Salary Costs	1 071 000	896 000	985 000	1 086 000
Depreciation	239 000	223 000	41 000	9 000
Impairment	0	0	0	0
Expenditure	12 199 000	11 764 000	9 081 000	6 759 000
Operating Profit	−11 785 000	−11 133 000	−7 583 000	−6 151 000
Financial Income	11 000	2 000	18 000	90 000
Financial Costs	123 000	98 000	35 000	0
Financial Balance	−112 000	−96 000	−17 000	90 000
Dividends	0	0	0	0
Net Income	−11 898 000	−11 228 000	−7 601 000	−6 062 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	833 000	833 000	833 000	833 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	1 147 000	1 287 000	1 277 000	8 000
Total Tangible Assets	1 147 000	1 287 000	1 277 000	8 000
Total Fiancial Fixed Assets	2 000	2 000	2 000	2 000
Total Fixed Assets	1 982 000	2 123 000	2 112 000	843 000
Stock	36 000	44 000	44 000	69 000
Total Investments	0	0	0	0
Cash, Bank	574 000	1 961 000	2 095 000	2 613 000
Total Current Assets	15 113 000	14 280 000	4 470 000	4 834 000
Total Assets	17 095 000	16 402 000	6 582 000	5 677 000
Total Equity	3 454 000	3 352 000	4 580 000	4 681 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	1 391 000	1 948 000	1 742 000	743 000
Unpaid Taxes	112 000	76 000	116 000	110 000
Dividends	0	0	0	0
Other Current Debt	12 137 000	11 026 000	143 000	143 000
Total Current Debt	13 640 000	13 050 000	2 002 000	996 000
Total Equity and Debt	17 095 000	16 402 000	6 582 000	5 677 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−344,47 %	−334,96 %	−165,96 %	−129,5 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	−2 799,29 %	−1 764,34 %	−497,57 %	−992,1 %
Current Ratio	1,11	1,09	2,23	4,85
Quick Ratio	1,11	1,1	2,28	5,21
Equity Ratio	0,2	0,2	0,7	0,82
Gross Profit Margin	35,63 %	52,14 %	89,7 %	91,13 %